Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-21-005364
Filing Date
2021-08-12
Accepted
2021-08-12 10:10:47
Documents
55
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nbio_10q.htm   iXBRL 10-Q 411236
2 CERTIFICATION nbio_ex311.htm EX-31.1 9481
3 CERTIFICATION nbio_ex312.htm EX-31.2 9565
4 CERTIFICATION nbio_ex321.htm EX-32.1 3864
5 CERTIFICATION nbio_ex322.htm EX-32.2 3942
  Complete submission text file 0001477932-21-005364.txt   2679617

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nbio-20210630.xsd EX-101.SCH 45931
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE nbio-20210630_lab.xml EX-101.LAB 221436
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nbio-20210630_cal.xml EX-101.CAL 33338
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nbio-20210630_pre.xml EX-101.PRE 181980
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nbio-20210630_def.xml EX-101.DEF 82196
11 EXTRACTED XBRL INSTANCE DOCUMENT nbio_10q_htm.xml XML 333604
Mailing Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960
Business Address 623 17TH STREET, SUITE 4 VERO BEACH FL 32960 612-961-5656
Nascent Biotech Inc. (Filer) CIK: 0001622057 (see all company filings)

EIN.: 450612715 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 000-55299 | Film No.: 211165825
SIC: 2834 Pharmaceutical Preparations